JAAPA CME Post-Test May 2021

Diagnosing and Managing Patients with Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic, progressive, inflammatory condition that affects about 1% of the world’s population. The multifactorial nature of RA has created continuous research discoveries leading to improved identification of specific pathways for the pathogenesis of RA. Improved understanding of the pathways has allowed the development of new targeted drugs. Clinicians must understand the most common pathways for pathogenesis of RA, proper diagnostic techniques, and the appropriate management of this disease given the many possible options at their disposal.

Learning Objectives

  • Compare and contrast the presentation of RA with other common joint diseases
  • Analyze the most appropriate tests for diagnostic workup of RA
  • Summarize and recommend treatments for RA based on patient needs

Managing Patients with High-risk Breast Lesions: Precursors on the Breast Neoplasia Pathway

Breast cancer remains the most commonly diagnosed cancer among women. Imaging abnormalities may be noted on routine breast cancer screenings and require biopsy for further evaluation. Atypia and carcinoma in situ are nonmalignant lesions identified via breast biopsy and are associated with an increased risk of invasive carcinoma. Because of the lack of specialized breast cancer prevention and risk reduction programs, patients may not be able to access optimal management of the various subtypes of atypia and carcinoma in situ. By understanding the pathology of high-risk breast lesions and the resulting elevated cancer risk, healthcare providers, specifically primary care providers, can better counsel, manage, and treat patients to provide comprehensive quality care.

Learning Objectives

  • Identify risk related to various breast pathologies and their corresponding primary management intervention and future cancer risk
  • Understand the role of risk prediction models to assess an individual’s breast cancer risk
  • Review treatment options for risk-reducing medication for pre- and post-menopausal women, as well as the adverse reactions associated with each risk-reducing medication

AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.